Answers are grounded in this paper and cite their sources.
A chronic systemic inflammatory response is clearly implicated in the progressive nutritional and functional decline in the cancer patients and their subsequent poor outcome. Systemic inflammation-based prognostic scores not only identify patients at risk but also provide well defined therapeutic targets for future clinical trials targeting nutritional decline.
No takes yet. Share an insight, caveat, or question.
Donald C. McMillan (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: